TAG, TB CAB, India CAB open letter to Immunoshop

Re: Marketing and use of TB Platinum for active TB in India and high TB burden countries

You can download from here an open letter from Treatment Action Group (TAG), members of the Global TB Community Advisory Board (TB CAB) as well as civil society in India who are concerned about Immunoshop's TB Platinum being used to detect active TB disease in the private sector (where serology use was rampant and has now been banned). The letter urges the company and its distributors to market the test as the label indicates and take action to stop the unethical, off-label use of the test for active TB.

A similar open letter was sent to Qiagen in May about their marketing of QuantiFERON-TB Gold in India.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Treatment Action Group, TB CAB, India CAB

Published: July 3, 2013, 10:56 a.m.

Last updated: July 3, 2013, 11:11 a.m.

Tags: None

Print Share